Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
ProQR Therapeutics N.V. (PRQR) had Gross Margin of 100.00% for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$5.93M |
|
$-14.33M |
|
-- |
|
$5.93M |
|
$21.05M |
|
$-15.12M |
|
$0.79M |
|
$-14.33M |
|
$-14.33M |
|
$-14.33M |
|
$-14.33M |
|
$-14.33M |
|
$-14.33M |
|
$-15.12M |
|
$-14.24M |
|
141.23M |
|
141.23M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$124.37M |
|
$12.71M |
|
$12.71M |
|
$137.08M |
|
$38.79M |
|
-- |
|
$19.81M |
|
$58.60M |
|
$78.48M |
|
$78.48M |
|
$78.48M |
|
143.47M |
|
| Cash Flow Statement Financials | |
$-42.59M |
|
$-0.93M |
|
$55.17M |
|
$106.37M |
|
$118.54M |
|
$12.17M |
|
$4.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.21 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
|
Gross Margin |
100.00% |
-254.80% |
|
-254.80% |
|
-- |
|
-241.45% |
|
-241.45% |
|
$-43.52M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
1.20 |
|
74.81 |
|
-18.25% |
|
-18.25% |
|
-10.45% |
|
-18.25% |
|
$0.55 |
|
$-0.31 |
|
$-0.30 |
|